Search Results
Mar 10, 2026, 08:13 ET Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model
HT-VA restores cholesterol to control-diet levels and maintains lower triglycerides compared with semaglutide in western diet–fed female miceTreatment preserved hepatic autophagy and maintained normal liver cellular homeostasisFindings support continued development
More news about: Hoth Therapeutics, Inc.
Mar 10, 2026, 07:02 ET Zemcelpro® (dorocubicel) Positive Results in High- and Very High-Risk Blood Cancers to be Reported at the EBMT 2026 Annual Meeting
Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood.
More news about: ExCellThera
Mar 10, 2026, 07:02 ET Zemcelpro® (dorocubicel) Positive Results in High- and Very High-Risk Blood Cancers to be Reported at the EBMT 2026 Annual Meeting
Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood.
More news about: ExCellThera
Mar 10, 2026, 07:02 ET Zemcelpro® (dorocubicel) : des résultats positifs dans les cancers du sang à haut et très haut risque seront présentés lors du congrès annuel 2026 de l'EBMT
Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood.
More news about: ExCellThera
Mar 10, 2026, 04:00 ET United Imaging Strengthens Presence in Europe with Comprehensive Innovation Portfolio at ECR 2026
institutions and organizations across more than half of European countries, delivering innovation across all imaging modalities. Representative partners include HT Medica, KU Leuven, ASST Grande Ospedale Metropolitano Niguarda, and Centre Léon Bérard. Globally, the company has launched more than 100 groundbreaking
More news about: United Imaging Healthcare Co., Ltd.
Mar 04, 2026, 09:00 ET Midmark RTLS Introduces a Smarter Hybrid Approach to RTLS with BLE and Wireless IR
other EMRs."Healthcare leaders shouldn't have to choose between enterprise-wide visibility and room-certain automation—they need both," said HT Snowday, senior director for Midmark RTLS. "Our Hybrid Sensory Network uses BLE as a scalable foundation and adds wireless IR precision only where it
More news about: Midmark RTLS
Mar 04, 2026, 08:31 ET Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program
OpenAI-powered API platform has been integrated into the HT-KIT development workflow to support preclinical data analysis, molecular modeling of KIT-driven pathways, and preparation of regulatory documentation ahead of IND submission.HT-KIT results below have shown success in rare cancers
More news about: Hoth Therapeutics, Inc.
Feb 27, 2026, 11:44 ET Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
lasting under an hour. The Dublin-based company's approach to treatment-resistant depression differs from oral psychedelic programs in that it targets 5-HT receptor subtypes through a rapid-onset delivery mechanism. The company has positioned GH001 as a potential practice-changing option for the roughly
More news about: Equity Insider
Feb 26, 2026, 16:30 ET Nomad Foods Annual Report Available to Shareholders
request a hard copy of the Company's Annual Report, free of charge, by contacting the Company at Nomad Foods, Forge, 43 Church Street West, Woking GU21 6HT, Attention: Investor Relations. If shareholders prefer, they can also request a hard copy by emailing
More news about: Nomad Foods Limited
Feb 26, 2026, 09:16 ET Securus Technologies Joins National Anti-Trafficking Leader In Our Backyard To Support and Empower Santa Clara Community Against Human Trafficking During Large Scale Event Activation
trafficking by empowering communities to prevent this atrocity and creating access to freedom for victims of human trafficking (HT). Exposed to the devastating realities of HT, IOB Founder Nita Belles was driven to take action to stop the exploitation of children, women, and men. Her book, In Our Backyard,
More news about: Securus Technologies
Feb 25, 2026, 08:00 ET Scopio Labs Achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms
digital morphology platforms in the European Union. The certification covers the company's QMS and full technical documentation for the X100 and X100HT platforms, including its Full-Field Peripheral Blood Smear (FF-PBS) Application with RBC AI-powered decision support. By meeting these rigorous EU standards,
More news about: Scopio Labs
Feb 24, 2026, 17:31 ET Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight
drug-resistant epilepsy and other neurological conditions.Bright Minds Bio's BMB-101 is a first-in-class, structure-guided agonist of the 5-HT2C receptor that favors Gq-protein signaling. It is purposefully designed for chronic neurological diseases in which tolerance and treatment resistance
More news about: DelveInsight Business Research, LLP
Feb 24, 2026, 16:15 ET HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES
investigational site network as surging patient demand outpaces capacity at existing sites — a direct reflection of the compelling early clinical results HT-001 has produced and the desperate unmet need it addresses.
More news about: Hoth Therapeutics, Inc.
Feb 24, 2026, 16:05 ET MATSON, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS; PROVIDES 2026 OUTLOOK
Time:4:30 p.m. ET / 1:30 p.m. PT / 11:30 a.m. HT
More news about: Matson, Inc.
Feb 20, 2026, 17:59 ET Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation
chemical entity, rapidly interconverts to iloperidone, providing dual active molecules that work in tandem by antagonizing dopamine D2, serotonin 5-HT2A, and alpha1-adrenergic receptors to modulate key pathways in these disorders. Its safety profile aligns closely with that established for iloperidone.BYSANTI™'s
More news about: Vanda Pharmaceuticals Inc.
Feb 18, 2026, 16:30 ET Johnson Controls signs agreement to acquire Alloy Enterprises, strengthening data center thermal management leadership
YK-HT two-stage economized centrifugal chiller — almost 30% smaller than alternatives, requiring up to 60% fewer dry coolers and delivering the industry's
More news about: Johnson Controls International plc
Feb 18, 2026, 13:40 ET SprintRay Previews Multi-Unit Chairside Production with Midas at Chicago Midwinter
available across key restorative materials, including:SprintRay OnX Tough 2SprintRay Digital TempSprintRay Crown HTThese capsules are designed to transform Midas into a true chairside restoration platform, supporting more complex cases in a single visit.Multi-unit
More news about: SprintRay, Inc.
Feb 11, 2026, 04:11 ET WORLD CLIMATE ACTION LEADERS, CITIZEN GROUPS, CORPORATES TO CONVERGE IN MUMBAI FOR GLOBAL SOUTH'S FIRST MUMBAI CLIMATE WEEK
ISEG Foundation, alongside sectoral experts and ecosystem collaborators. The urban resilience stream is anchored by WRI India in partnership with the HT Parekh Foundation and India Climate Collaborative as thematic partners.Detailed Agenda:A detailed agenda of all three thematic pillars
More news about: Mumbai Climate Week (MCW)
Feb 10, 2026, 08:30 ET Hoth Therapeutics Announces Groundbreaking Positive Results: Hoth's HT-VA GDNF Surpasses Semaglutide in Weight Loss, Glucose Control, and Liver Health in Obesity Model
trials in 2027.Hoth's GDNF program is part of a robust pipeline, including HT-001 (Phase 2 for cancer-related skin toxicities), HT-KIT (Orphan Drug Designation for mast cell cancers), and HT-ALZ (for Alzheimer's).About Hoth Therapeutics, Inc.Hoth
More news about: Hoth Therapeutics, Inc.
Feb 05, 2026, 08:03 ET Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency Assets
cryptocurrency assets, and its maximum exposure never reached more than $350,000 USD over the last year. Hoth continues to execute on its HT-001 clinical trial and continues progressing its pipeline to further clinical trials in both oncology and obesity.
More news about: Hoth Therapeutics, Inc.
Feb 04, 2026, 10:15 ET Spin-on Carbon Market worth $0.81 billion by 2032 - Exclusive Report by MarketsandMarkets™
fastest market growth during the forecast period."The hot-temperature spin-on carbon (HT-SOC) segment is projected to lead the market by 2032."By type, the hot-temperature spin-on carbon (HT-SOC) segment is projected to dominate the market by 2032 due to its superior thermal stability,
More news about: MarketsandMarkets
Feb 03, 2026, 09:22 ET Midmark RTLS launches BLE Sensory Network for smarter, scalable RTLS
capabilities."Healthcare organizations are under increasing pressure to improve staff safety, optimize asset utilization and do more with limited resources," said HT Snowday, senior director for Midmark RTLS. "Midmark CareFlow RTLS powered by BLE removes traditional deployment barriers and gives facilities a faster,
More news about: Midmark RTLS
Feb 03, 2026, 04:31 ET Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors
oncological diseases. By leveraging its proprietary core technology platforms—including the H³ Antibody Discovery platform, the SynTracer® HT Endocytosis platform, and the Flexibody® Bispecific platform—the company develops highly differentiated innovative medicines to address significant
More news about: Biosion, Inc.
Feb 02, 2026, 13:39 ET FAMILY OF ANTONIO MAYS JR. CALLS FOR RELEASE OF BODY CAMERA FOOTAGE IN WAKE OF JURY VERDICT
https://www.dropbox.com/scl/fo/calggxhtanc2oeqzb33oy/AOSO1LVFTo8cMnm0OAfoaU4?rlkey=8w51hc3ht7vwy0ysool80b3av&e=1&st=rbsmnb4w&dl=0Contact:Evan M. OshanOshan & Associates
More news about: Oshan & Associates, P.C.
Feb 02, 2026, 10:00 ET New Rebate from Hankook Tire Offers Up to $100 Savings
with a $100 rebate on all Hankook Dynapro products, including the Dynapro evo AS and Dynapro HT2. From the all-season Dynapro evo AS designed for high-performance SUVs, to the durable Dynapro HT2 for year-round comfort on the highway in any season – the Dynapro lineup is optimized for strong driving
More news about: Hankook Tire America Corp.